triciribine phosphate has been researched along with epidermal growth factor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berndt, N; Betzi, S; Cheng, JQ; Lawrence, NJ; Pellecchia, M; Schönbrunn, E; Sebti, SM; Trinczek, B; Wu, B; Yang, H; Zhang, Z | 1 |
1 other study(ies) available for triciribine phosphate and epidermal growth factor
| Article | Year |
|---|---|
The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Acenaphthenes; Animals; Apoptosis; Cell Line, Tumor; Cell Membrane; Epidermal Growth Factor; Fluorescent Antibody Technique; Gene Amplification; Humans; Intracellular Signaling Peptides and Proteins; Magnetic Resonance Spectroscopy; Membrane Proteins; Phosphoproteins; Phosphorylation; Polymerase Chain Reaction; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Ribonucleotides; Signal Transduction; Surface Plasmon Resonance; TOR Serine-Threonine Kinases | 2010 |